Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

115.22
Delayed Data
As of Jan 18
 +0.27 / +0.23%
Today’s Change
93.05
Today|||52-Week Range
127.00
-0.46%
Year-to-Date
4 Top Biotech Mutual Funds for 2017
Jan 18 / Zacks.com - Paid Partner Content
Donald Trump Just Leveled Drug Companies With These 4 Words
Jan 14 / MotleyFool.com - Paid Partner Content
Hills Bank & Trust Co Buys CVS Health Corp, Alliance Data Systems Corp, Twenty-First ...
Jan 18 / GuruFocus News - Paid Partner Content
Terra Nova Asset Management LLC Buys Goldman Sachs Group Inc, Ulta Salon Cosmetics & ...
Jan 13 / GuruFocus News - Paid Partner Content
Is Donald Trump Celgene's Biggest Risk in 2017?
Jan 17 / MotleyFool.com - Paid Partner Content
Terra Nova Asset Management LLC Buys Goldman Sachs Group Inc, Ulta Salon Cosmetics & ...
Jan 13 / GuruFocus News - Paid Partner Content
Medidata Solutions Clinical Cloud Gets Picked by Celgene
Jan 17 / Zacks.com - Paid Partner Content
CT Financial Advisors LLC Buys Alphabet Inc, Alphabet Inc, United Therapeutics Corp, ...
Jan 12 / GuruFocus News - Paid Partner Content
Better Buy: Amgen Inc. vs. Celgene Corporation
Jan 17 / MotleyFool.com - Paid Partner Content
Trump Attacks Biotech & Pharma: ETFs Bleed
Jan 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close114.95
Today’s open115.10
Day’s range114.29 - 115.26
Volume4,041,063
Average volume (3 months)4,540,705
Market cap$89.3B
Dividend yield--
Data as of 01/18/2017

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+25.71%
Earnings growth (next 5 years)+21.22%
Revenue growth (last year)+16.47%
P/E ratio43.8
Price/Sales11.10
Price/Book15.31

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.68+0.88%
BMYBristol-Myers Squibb-0.21-0.37%
GSKGlaxoSmithKline-0.41-1.04%
AGNAllergan+1.78+0.83%
Data as of 01/18/2017

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$1.59
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts


Search for Jobs